Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about WNT: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | WNT |
| Summary | Category page for companies developing WNT signaling, hedgehog, and developmental pathway therapies for Alzheimer's disease - includes WNT modulators, beta-catenin stabilizers, porcupine inhibitors, and developmental pathway targeting companies. |
| Key Genes/Proteins | AMYLOID, CTNNB1, PFKM, DKK1 |
| Related Diseases | ALZHEIMER'S DISEASE |
| Linked Hypotheses | 1 hypotheses |
Knowledge base pages for this entity
graph TD
WNT["WNT"] -->|"causes"| Hepatocellular_Carcinoma["Hepatocellular Carcinoma"]
WNT["WNT"] -->|"activates"| Carcinoma["Carcinoma"]
WNT["WNT"] -->|"expressed in"| Cancer["Cancer"]
WNT["WNT"] -->|"expressed in"| Tumor["Tumor"]
WNT["WNT"] -->|"contributes to"| Tumor_1["Tumor"]
WNT["WNT"] -->|"contributes to"| Cancer_2["Cancer"]
FZD3["FZD3"] -->|"participates in"| WNT["WNT"]
FZD3_3["FZD3"] -->|"binds"| WNT["WNT"]
PSMB1["PSMB1"] -->|"activates"| WNT["WNT"]
BECN1["BECN1"] -->|"activates"| WNT["WNT"]
style WNT fill:#1b5e20,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| neurogenesis | regulates | process | 0.95 |
| synaptic plasticity | regulates | process | 0.95 |
| Synapse Remodeling | regulates | process | 0.90 |
| Neurodevelopment | involved_in | process | 0.90 |
| neuroinflammation | regulates | process | 0.90 |
| PFKM | downregulates | protein | 0.90 |
| Autophagy | interacts_with | process | 0.85 |
| vascular remodeling | modulates | process | 0.85 |
| autophagy | suppresses | process | 0.85 |
| Alzheimer's Disease | protects_against | disease | 0.85 |
| Parkinson's Disease | protects_against | disease | 0.85 |
| Amyotrophic Lateral Sclerosis | protects_against | disease | 0.85 |
| stroke | protects_against | disease | 0.85 |
| Hepatocellular Carcinoma | causes | disease | 0.80 |
| Autism-Like Behaviors | mediates | phenotype | 0.80 |
| Wnt signaling | participates_in | pathway | 0.80 |
| autophagy | mediates | process | 0.80 |
| endothelial cells | expressed_in | cell_type | 0.80 |
| Alzheimer's disease | dysregulated_in | disease | 0.80 |
| Inhibitory Neuron | activates | cell_type | 0.80 |
| PULMONARY HYPERTENSION | involved_in | entity | 0.75 |
| Pulmonary Arterial Hypertension | involved_in | disease | 0.75 |
| embryo development | modulates | process | 0.75 |
| oxidative stress response | participates_in | pathway | 0.70 |
| autophagy pathway | participates_in | pathway | 0.70 |
| neural stem cells | activates | cell_type | 0.70 |
| neural stem cells | regulates | cell_type | 0.70 |
| glioblastoma | activates | disease | 0.70 |
| Carcinoma | activates | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Tumor | contributes_to | disease | 0.65 |
| Cancer | contributes_to | disease | 0.65 |
| Cardiovascular | contributes_to | disease | 0.65 |
| Metabolic Syndrome | contributes_to | disease | 0.65 |
| Autoimmune | contributes_to | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Cancer | interacts_with | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Infection | therapeutic_target | disease | 0.65 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Fibrosis | regulates | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER'S DISEASE | associated_with | disease | 1.00 |
| AMYLOID | associated_with | protein | 0.98 |
| Bnt162B2 | associated_with | drug | 0.95 |
| CTNNB1 | involved_in | gene | 0.95 |
| Thermal adaptation | inhibits | process | 0.90 |
| DKK1 | inhibits | gene | 0.90 |
| Microglia | activates | cell_type | 0.85 |
| BNT162b2 | modulates | drug | 0.85 |
| NOTUM | inhibits | gene | 0.85 |
| SFRP1 | inhibits | gene | 0.85 |
| DVL3 | regulates | gene | 0.85 |
| PARKINSON'S DISEASE | associated_with | disease | 0.82 |
| MTOR | associated_with | gene | 0.82 |
| PI3K | associated_with | gene | 0.82 |
| NF-KB | associated_with | protein | 0.82 |
| FZD3 | participates_in | gene | 0.80 |
| GSK3B | inhibits | protein | 0.80 |
| APOE | associated_with | gene | 0.74 |
| AKT | associated_with | gene | 0.74 |
| PSMB1 | activates | gene | 0.70 |
| ATG | activates | gene | 0.70 |
| ATG | regulates | gene | 0.70 |
| BECN1 | regulates | gene | 0.70 |
| flavonoid | activates | compound | 0.70 |
| BECN1 | activates | gene | 0.66 |
| LRRK2 | associated_with | gene | 0.66 |
| LRP1 | associated_with | gene | 0.66 |
| ALS | associated_with | disease | 0.66 |
| FUS | associated_with | gene | 0.66 |
| MTOR | activates | gene | 0.66 |
| TAU | associated_with | protein | 0.66 |
| EGFR | activates | gene | 0.66 |
| TAU | phosphorylates | protein | 0.66 |
| BDNF | activates | gene | 0.66 |
| AUTISM | expressed_in | disease | 0.65 |
| BDNF | expressed_in | gene | 0.65 |
| STING | expressed_in | gene | 0.65 |
| MAPK | mediates | gene | 0.65 |
| RAPAMYCIN | regulates | drug | 0.65 |
| HIPPOCAMPUS | phosphorylates | brain_region | 0.65 |
| APP | associated_with | gene | 0.64 |
| CFTR | activates | gene | 0.60 |
| CGAS | activates | gene | 0.60 |
| JNK | activates | gene | 0.60 |
| LDLR | regulates | gene | 0.60 |
| CANCER | mediates | disease | 0.60 |
| CARCINOMA | regulates | disease | 0.60 |
| GSK3B | regulates | gene | 0.60 |
| LAMP1 | regulates | gene | 0.60 |
| RAS | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Inhibitory Neuron-Selective WNT Signaling Restoration | 0.390 | neurodegeneration | Which cell types show the most significa |
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| The Wnt3a/β-catenin/TCF7L2 signaling axis reduces the sensitivity of HER2-positi [PMID:32248976] | Shen G, Gao Q, Liu F, Zhang Y, Dai M et | Biochem Biophys Res Commun | 2020 | 0 |
| WNT signalling in the normal human adult testis and in male germ cell neoplasms. [PMID:32667987] | Young JC, Kerr G, Micati D, Nielsen JE, | Hum Reprod | 2020 | 0 |
| Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-cat [PMID:28811361] | Emons G, Spitzner M, Reineke S, Möller J | Mol Cancer Res | 2017 | 0 |
| Wnt-dependent T-cell factor-4 controls human etravillous trophoblast motility. [PMID:24605829] | Meinhardt G, Haider S, Haslinger P, Proe | Endocrinology | 2014 | 0 |
| Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signa [PMID:15650056] | Tickenbrock L, Schwäble J, Wiedehage M, | Blood | 2005 | 0 |